These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30153051)

  • 21. Effects of 0.005% latanoprost on ocular anterior structures and ciliary body thickness.
    Marchini G; Ghilotti G; Bonadimani M; Babighian S
    J Glaucoma; 2003 Aug; 12(4):295-300. PubMed ID: 12897573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ocular hypotensive effect of pilocarpine in latanoprost treated eyes; a pilot study].
    Teus Guezala MA ; Arranz Márquez E ; Morales Bertrand J ; Marcos De La Huerga A
    Arch Soc Esp Oftalmol; 2000 Nov; 75(11):735-740. PubMed ID: 11151262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of latanoprost when stored at room temperature.
    Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
    Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of topical administration of 2.0% pilocarpine on intraocular pressure and pupil size in cats.
    Wilkie DA; Latimer CA
    Am J Vet Res; 1991 Mar; 52(3):441-4. PubMed ID: 2035919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
    Richter M; Krauss AH; Woodward DF; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4419-26. PubMed ID: 14507888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
    Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH
    Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term effect of latanoprost on ocular circulation in ocular hypertension.
    Akarsu C; Bilgili YK; Taner P; Unal B; Ergin A
    Clin Exp Ophthalmol; 2004 Aug; 32(4):373-7. PubMed ID: 15281970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects.
    Takahashi M; Higashide T; Sakurai M; Sugiyama K
    J Glaucoma; 2008; 17(3):169-74. PubMed ID: 18414100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes.
    Lindén C; Alm A
    Arch Ophthalmol; 1997 Jul; 115(7):857-61. PubMed ID: 9230825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of intraocular pressure in mouse eyes treated with latanoprost.
    Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):146-50. PubMed ID: 11773025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
    Konstas AG; Voudouragkaki IC; Boboridis KG; Haidich AB; Paschalinou E; Giannopoulos T; Dragoumis ND; Makridis AK; Kahook MY
    Adv Ther; 2014 Jun; 31(6):592-603. PubMed ID: 24919410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma.
    Nakamoto K; Yasuda N
    J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular hypotensive effect of tafluprost in latanoprost low-responder cynomolgus monkeys.
    Kurashima H; Asai Y; Aihara M; Ishida N; Nakamura M; Araie M
    J Glaucoma; 2012 Feb; 21(2):123-8. PubMed ID: 21423041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.